1. Home
  2. IMRN vs QMCO Comparison

IMRN vs QMCO Comparison

Compare IMRN & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • QMCO
  • Stock Information
  • Founded
  • IMRN 1994
  • QMCO 1980
  • Country
  • IMRN Australia
  • QMCO United States
  • Employees
  • IMRN N/A
  • QMCO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • QMCO Electronic Components
  • Sector
  • IMRN Health Care
  • QMCO Technology
  • Exchange
  • IMRN Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • IMRN 9.2M
  • QMCO 98.8M
  • IPO Year
  • IMRN N/A
  • QMCO N/A
  • Fundamental
  • Price
  • IMRN $1.83
  • QMCO $8.19
  • Analyst Decision
  • IMRN Strong Buy
  • QMCO Hold
  • Analyst Count
  • IMRN 1
  • QMCO 2
  • Target Price
  • IMRN $5.00
  • QMCO $19.00
  • AVG Volume (30 Days)
  • IMRN 43.6K
  • QMCO 710.6K
  • Earning Date
  • IMRN 08-29-2025
  • QMCO 09-10-2025
  • Dividend Yield
  • IMRN N/A
  • QMCO N/A
  • EPS Growth
  • IMRN N/A
  • QMCO N/A
  • EPS
  • IMRN N/A
  • QMCO N/A
  • Revenue
  • IMRN $4,777,422.00
  • QMCO $266,079,000.00
  • Revenue This Year
  • IMRN N/A
  • QMCO $7.49
  • Revenue Next Year
  • IMRN N/A
  • QMCO $3.22
  • P/E Ratio
  • IMRN N/A
  • QMCO N/A
  • Revenue Growth
  • IMRN 48.63
  • QMCO N/A
  • 52 Week Low
  • IMRN $1.50
  • QMCO $2.88
  • 52 Week High
  • IMRN $2.87
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 50.67
  • QMCO 54.16
  • Support Level
  • IMRN $1.80
  • QMCO $7.07
  • Resistance Level
  • IMRN $1.94
  • QMCO $7.87
  • Average True Range (ATR)
  • IMRN 0.07
  • QMCO 0.34
  • MACD
  • IMRN -0.00
  • QMCO -0.32
  • Stochastic Oscillator
  • IMRN 42.11
  • QMCO 95.01

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

Share on Social Networks: